Skip to main content
Clinical Trials/RBR-6fntmd
RBR-6fntmd
Active, not recruiting
未知

Assessment of the potential of hearing improvement by performing a double-blind, randomized, cross-over study in the state of São Paulo. Consumer satisfaction with sound amplification in everyday life with a new high-performance hearing aid - WHO Inc. compared to advanced digital hearing aids available on the market

niversidade de São Paulo0 sitesApril 30, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
hearing health and hearing loss
Sponsor
niversidade de São Paulo
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 30, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade de São Paulo

Eligibility Criteria

Inclusion Criteria

  • Sensorineural hearing loss with tonal thresholds of 25\-85 dB NA per octave frequency between 250 and 4000 Hz, in 4 frequencies up to the threshold of 30\-70 dB NA;
  • Not Protected with AASI in the last year;
  • Being in good health (self report);
  • Present normal vision or corrected vision for normal vision (less than or equal to 20 / 50\)
  • Age between 21 and 75 years;
  • Maintain ability to speak, read and write;
  • No evidence of significant accumulation of wax or a foreign body in your external ear canal;

Exclusion Criteria

  • Presence of acute or chronic limiting diseases;
  • Presence of unilateral or worsening hearing loss in the last 90 days;
  • Blockage of the external ear canal or Ear infection or clogged ear sensation;
  • Otorrhea in the last 90 days;
  • Presence of sudden hearing loss in the last 90 days;
  • Dizziness or vertigo at the time of selection;
  • Presence of any congenital or traumatic deformity of the ear;
  • Presence of pain or discomfort in the ear;
  • Presence of conductive hearing loss or asymmetric hearing loss;
  • Presence of hearing loss that exceeds the limits that can be successfully aided by hearing loss (hearing loss);

Outcomes

Primary Outcomes

Not specified

Similar Trials